Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 106 articles: HTML format

Single Articles

September 2022
1. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al
   SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
   Biochem Biophys Res Commun. 2022;620:8-14.
   PubMed     Abstract available
   
   
   August 2022
2. LI H, Ren H, Cao L, Guo J, et al
   Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice.
   Biochem Biophys Res Commun. 2022;618:54-60.
   PubMed     Abstract available
   
   
   
3. WEI W, Kong N, Liu MZ, Han T, et al
   Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease.
   Biochem Biophys Res Commun. 2022;616:8-13.
   PubMed     Abstract available
   
   
   
4. ZHANG B, Li Y, Feng Q, Song L, et al
   Structural insights into ORF10 recognition by ZYG11B.
   Biochem Biophys Res Commun. 2022;616:14-18.
   PubMed     Abstract available
   
   
   July 2022
5. SUGAMOTO K, Tanaka YL, Saito A, Goto Y, et al
   Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
   Biochem Biophys Res Commun. 2022;615:56-62.
   PubMed     Abstract available
   
   
   
6. MINAGAWA H, Sawa H, Fujita T, Kato S, et al
   A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
   Biochem Biophys Res Commun. 2022;614:207-212.
   PubMed     Abstract available
   
   
   
7. DUAN L, Yin H, Liu J, Wang W, et al
   Fetal neurodevelopmental spatio-temporal dynamic transcriptional landscape of maternal insult-induce autism spectrum disorder risk.
   Biochem Biophys Res Commun. 2022;614:183-190.
   PubMed     Abstract available
   
   
   June 2022
8. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al
   Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
   Biochem Biophys Res Commun. 2022;620:180-187.
   PubMed     Abstract available
   
   
   May 2022
9. MIYOSHI H, Ichinohe R, Koshikawa T
   High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations.
   Biochem Biophys Res Commun. 2022;606:128-134.
   PubMed     Abstract available
   
   
   
10. WANG L, Zhao L, Li Y, Ma P, et al
    Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system.
    Biochem Biophys Res Commun. 2022;606:23-28.
    PubMed     Abstract available
    
    
    
11. LIU P, Zhang Y, Li Z, Huang J, et al
    Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;606:17-22.
    PubMed     Abstract available
    
    
    
12. GHAZANFARI D, Courreges MC, Belinski L, Bergmeier SC, et al
    Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19.
    Biochem Biophys Res Commun. 2022;605:171-176.
    PubMed     Abstract available
    
    
    
13. WU Q, Yan S, Wang Y, Li M, et al
    Discovery of 4'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor.
    Biochem Biophys Res Commun. 2022;604:76-82.
    PubMed     Abstract available
    
    
    April 2022
14. YUE K, Yao B, Shi Y, Yang Y, et al
    The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Biochem Biophys Res Commun. 2022;601:129-136.
    PubMed     Abstract available
    
    
    February 2022
15. HEALY EF
    How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17.
    Biochem Biophys Res Commun. 2022;593:52-56.
    PubMed     Abstract available
    
    
    
16. KOLEY T, Kumar M, Goswami A, Ethayathulla AS, et al
    Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus.
    Biochem Biophys Res Commun. 2022;592:51-53.
    PubMed     Abstract available
    
    
    
17. RATH SL, Padhi AK, Mandal N
    Scanning the RBD-ACE2 molecular interactions in Omicron variant.
    Biochem Biophys Res Commun. 2022;592:18-23.
    PubMed     Abstract available
    
    
    
18. LEE JW, Kim MN, Kim EG, Leem JS, et al
    Chitinase 3-like 1 is involved in the induction of IL-8 expression by double-stranded RNA in airway epithelial cells.
    Biochem Biophys Res Commun. 2022;592:106-112.
    PubMed     Abstract available
    
    
    
19. CHEN J, Zhang Y, Zeng D, Zhang B, et al
    Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;591:118-123.
    PubMed     Abstract available
    
    
    
20. MAO XD, Li T, Xu Z, Liu K, et al
    Pathogenesis of COVID-19 and the quality control of nucleic acid detection.
    Biochem Biophys Res Commun. 2022;591:137-142.
    PubMed     Abstract available
    
    
    
21. CHIOU WC, Chen JC, Chen YT, Yang JM, et al
    The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Biochem Biophys Res Commun. 2022;591:130-136.
    PubMed     Abstract available
    
    
    January 2022
22. LUPALA CS, Ye Y, Chen H, Su XD, et al
    Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
    Biochem Biophys Res Commun. 2022;590:34-41.
    PubMed     Abstract available
    
    
    
23. HOSHINO F, Sakane F
    Docosahexaenoic acid-containing phosphatidic acid interacts with clathrin coat assembly protein AP180 and regulates its interaction with clathrin.
    Biochem Biophys Res Commun. 2022;587:69-77.
    PubMed     Abstract available
    
    
    
24. MAKIYAMA K, Hazawa M, Kobayashi A, Lim K, et al
    NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells.
    Biochem Biophys Res Commun. 2022;586:137-142.
    PubMed     Abstract available
    
    
    
25. OSTROV DA, Knox GW
    Emerging mutation patterns in SARS-CoV-2 variants.
    Biochem Biophys Res Commun. 2022;586:87-92.
    PubMed     Abstract available
    
    
    November 2021
26. VICTOR J, Deutsch J, Whitaker A, Lamkin EN, et al
    SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
    Biochem Biophys Res Commun. 2021;579:141-145.
    PubMed     Abstract available
    
    
    
27. ZHENG L, Ma Y, Chen M, Wu G, et al
    SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
    Biochem Biophys Res Commun. 2021;579:69-75.
    PubMed     Abstract available
    
    
    
28. RYU DK, Kang B, Noh H, Woo SJ, et al
    The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;578:91-96.
    PubMed     Abstract available
    
    
    
29. SASAKI M, Kishimoto M, Itakura Y, Tabata K, et al
    Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
    Biochem Biophys Res Commun. 2021;577:146-151.
    PubMed     Abstract available
    
    
    October 2021
30. BARAL P, Bhattarai N, Hossen ML, Stebliankin V, et al
    Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
    Biochem Biophys Res Commun. 2021;574:14-19.
    PubMed     Abstract available
    
    
    September 2021
31. LONG Y, Song S, Luo F, Han X, et al
    A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
    Biochem Biophys Res Commun. 2021;571:152-158.
    PubMed     Abstract available
    
    
    
32. BEGUM F, Srivastava AK, Ray U
    Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Biochem Biophys Res Commun. 2021;571:26-31.
    PubMed     Abstract available
    
    
    
33. OBA M, Rongduo W, Saito A, Okabayashi T, et al
    Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
    Biochem Biophys Res Commun. 2021;570:21-25.
    PubMed     Abstract available
    
    
    August 2021
34. RYU DK, Song R, Kim M, Kim YI, et al
    Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
    Biochem Biophys Res Commun. 2021;566:135-140.
    PubMed     Abstract available
    
    
    
35. JIN D, Wei J, Sun J
    Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
    Biochem Biophys Res Commun. 2021;566:45-52.
    PubMed     Abstract available
    
    
    
36. HUANG RY, Herr DR
    Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein.
    Biochem Biophys Res Commun. 2021;565:8-13.
    PubMed     Abstract available
    
    
    July 2021
37. OHKI S, Imamura T, Higashimura Y, Matsumoto K, et al
    Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Biochem Biophys Res Commun. 2021;563:92-97.
    PubMed     Abstract available
    
    
    June 2021
38. HATAKEYAMA D, Masuda T, Miki R, Ohtsuki S, et al
    In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
    Biochem Biophys Res Commun. 2021;557:273-279.
    PubMed     Abstract available
    
    
    
39. ZHAO L, Hao Y, Song Z, Fan Y, et al
    TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Biochem Biophys Res Commun. 2021;556:87-92.
    PubMed     Abstract available
    
    
    May 2021
40. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    PubMed     Abstract available
    
    
    
41. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    PubMed     Abstract available
    
    
    
42. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    PubMed     Abstract available
    
    
    
43. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    PubMed     Abstract available
    
    
    
44. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    PubMed     Abstract available
    
    
    
45. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    PubMed     Abstract available
    
    
    April 2021
46. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    PubMed     Abstract available
    
    
    March 2021
47. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    PubMed     Abstract available
    
    
    
48. SAKURAI Y, Ngwe Tun MM, Kurosaki Y, Sakura T, et al
    5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
    Biochem Biophys Res Commun. 2021;545:203-207.
    PubMed     Abstract available
    
    
    
49. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    PubMed     Abstract available
    
    
    
50. SMITS VAJ, Hernandez-Carralero E, Paz-Cabrera MC, Cabrera E, et al
    The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Biochem Biophys Res Commun. 2021;543:45-49.
    PubMed     Abstract available
    
    
    January 2021
51. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;538:231-237.
    PubMed     Abstract available
    
    
    
52. SANTORO MG, Carafoli E
    Remdesivir: From Ebola to COVID-19.
    Biochem Biophys Res Commun. 2021;538:145-150.
    PubMed     Abstract available
    
    
    
53. MOORE KM, Suthar MS
    Comprehensive analysis of COVID-19 during pregnancy.
    Biochem Biophys Res Commun. 2021;538:180-186.
    PubMed     Abstract available
    
    
    
54. VIANELLO C, Strozzi F, Mocellin P, Cimetta E, et al
    A perspective on early detection systems models for COVID-19 spreading.
    Biochem Biophys Res Commun. 2021;538:244-252.
    PubMed     Abstract available
    
    
    
55. PASETTO D, Lemaitre JC, Bertuzzo E, Gatto M, et al
    Range of reproduction number estimates for COVID-19 spread.
    Biochem Biophys Res Commun. 2021;538:253-258.
    PubMed     Abstract available
    
    
    
56. JANS DA, Wagstaff KM
    The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
    Biochem Biophys Res Commun. 2021;538:163-172.
    PubMed     Abstract available
    
    
    
57. REZNIKOV LR, Norris MH, Vashisht R, Bluhm AP, et al
    Identification of antiviral antihistamines for COVID-19 repurposing.
    Biochem Biophys Res Commun. 2021;538:173-179.
    PubMed     Abstract available
    
    
    
58. SANTOPOLO S, Riccio A, Santoro MG
    The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Biochem Biophys Res Commun. 2021;538:80-87.
    PubMed     Abstract available
    
    
    
59. BACCA E, Digaetano M, Meschiari M, Franceschini E, et al
    Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
    Biochem Biophys Res Commun. 2021;538:151-155.
    PubMed     Abstract available
    
    
    
60. WATASHI K
    Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Biochem Biophys Res Commun. 2021;538:137-144.
    PubMed     Abstract available
    
    
    
61. WALSH MA, Grimes JM, Stuart DI
    Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
    Biochem Biophys Res Commun. 2021;538:40-46.
    PubMed     Abstract available
    
    
    
62. MOURIER T, Sadykov M, Carr MJ, Gonzalez G, et al
    Host-directed editing of the SARS-CoV-2 genome.
    Biochem Biophys Res Commun. 2021;538:35-39.
    PubMed     Abstract available
    
    
    
63. CHENG HY, Huang AS
    Proactive and blended approach for COVID-19 control in Taiwan.
    Biochem Biophys Res Commun. 2021;538:238-243.
    PubMed     Abstract available
    
    
    
64. KALFAOGLU B, Almeida-Santos J, Tye CA, Satou Y, et al
    T-cell dysregulation in COVID-19.
    Biochem Biophys Res Commun. 2021;538:204-210.
    PubMed     Abstract available
    
    
    
65. JACKSON CB, Zhang L, Farzan M, Choe H, et al
    Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Biochem Biophys Res Commun. 2021;538:108-115.
    PubMed     Abstract available
    
    
    
66. KENNY G, Mallon PW
    COVID19- clinical presentation and therapeutic considerations.
    Biochem Biophys Res Commun. 2021;538:125-131.
    PubMed     Abstract available
    
    
    
67. SCHENKELBERG T
    Vaccine-induced protection in aging adults and pandemic response.
    Biochem Biophys Res Commun. 2021;538:218-220.
    PubMed    
    
    
    
68. PLATTO S, Wang Y, Zhou J, Carafoli E, et al
    History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.
    Biochem Biophys Res Commun. 2021;538:14-23.
    PubMed     Abstract available
    
    
    
69. GROVES DC, Rowland-Jones SL, Angyal A
    The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Biochem Biophys Res Commun. 2021;538:104-107.
    PubMed     Abstract available
    
    
    
70. GIOVANETTI M, Benedetti F, Campisi G, Ciccozzi A, et al
    Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
    Biochem Biophys Res Commun. 2021;538:88-91.
    PubMed     Abstract available
    
    
    
71. DIPIAZZA AT, Graham BS, Ruckwardt TJ
    T cell immunity to SARS-CoV-2 following natural infection and vaccination.
    Biochem Biophys Res Commun. 2021;538:211-217.
    PubMed     Abstract available
    
    
    
72. CARRILLO J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, et al
    Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
    Biochem Biophys Res Commun. 2021;538:187-191.
    PubMed     Abstract available
    
    
    
73. SARVER DC, Wong GW
    Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
    Biochem Biophys Res Commun. 2021;538:92-96.
    PubMed     Abstract available
    
    
    
74. BAXTER C, Abdool Karim Q, Abdool Karim SS
    Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
    Biochem Biophys Res Commun. 2021;538:221-225.
    PubMed    
    
    
    
75. LAI CKC, Lam W
    Laboratory testing for the diagnosis of COVID-19.
    Biochem Biophys Res Commun. 2021;538:226-230.
    PubMed     Abstract available
    
    
    
76. FANTINI J, Chahinian H, Yahi N
    Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
    Biochem Biophys Res Commun. 2021;538:132-136.
    PubMed     Abstract available
    
    
    
77. PLATTO S, Zhou J, Wang Y, Wang H, et al
    Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.
    Biochem Biophys Res Commun. 2021;538:2-13.
    PubMed     Abstract available
    
    
    
78. ZINZULA L, Basquin J, Bohn S, Beck F, et al
    High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
    Biochem Biophys Res Commun. 2021;538:54-62.
    PubMed     Abstract available
    
    
    
79. CARAFOLI E
    Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
    Biochem Biophys Res Commun. 2021;538:156-162.
    PubMed     Abstract available
    
    
    
80. JIANG Y, Yin W, Xu HE
    RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
    Biochem Biophys Res Commun. 2021;538:47-53.
    PubMed     Abstract available
    
    
    
81. 
    Editorial.
    Biochem Biophys Res Commun. 2021;538:1.
    PubMed    
    
    
    
82. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;538:97-103.
    PubMed     Abstract available
    
    
    
83. GU L, Zhou Y, Wang G, Deng H, et al
    Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
    Biochem Biophys Res Commun. 2021;540:29-36.
    PubMed     Abstract available
    
    
    
84. SHARMA A, Preece B, Swann H, Fan X, et al
    Structural stability of SARS-CoV-2 virus like particles degrades with temperature.
    Biochem Biophys Res Commun. 2021;534:343-346.
    PubMed     Abstract available
    
    
    
85. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;534:830-836.
    PubMed     Abstract available
    
    
    
86. LIMA MA, Skidmore M, Khanim F, Richardson A, et al
    Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
    Biochem Biophys Res Commun. 2021;534:485-490.
    PubMed     Abstract available
    
    
    
87. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;534:374-380.
    PubMed     Abstract available
    
    
    November 2020
88. JEREMIAH SS, Miyakawa K, Morita T, Yamaoka Y, et al
    Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;533:195-200.
    PubMed     Abstract available
    
    
    October 2020
89. TUNG HYL, Limtung P
    Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
    Biochem Biophys Res Commun. 2020;532:134-138.
    PubMed     Abstract available
    
    
    September 2020
90. CHEN P, Zeng Z, Du H
    Establishment and validation of a drug-target microarray for SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;530:4-9.
    PubMed     Abstract available
    
    
    
91. SINGH TOMAR PP, Arkin IT
    SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
    Biochem Biophys Res Commun. 2020;530:10-14.
    PubMed     Abstract available
    
    
    
92. TAKEDA Y, Uchiumi H, Matsuda S, Ogawa H, et al
    Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus.
    Biochem Biophys Res Commun. 2020;530:1-3.
    PubMed     Abstract available
    
    
    
93. XU H, Qian J, Song Y, Ming D, et al
    The adaptability of H9N2 avian influenza A virus to humans: A comparative docking simulation study.
    Biochem Biophys Res Commun. 2020;529:963-969.
    PubMed     Abstract available
    
    
    August 2020
94. ZHANG H, Tu J, Cao C, Yang T, et al
    Proteasome activator PA28gamma-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;529:251-256.
    PubMed     Abstract available
    
    
    July 2020
95. CHOI JY, Lee HK, Park JH, Cho SJ, et al
    Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
    Biochem Biophys Res Commun. 2020;528:413-419.
    PubMed     Abstract available
    
    
    
96. BONGINI P, Trezza A, Bianchini M, Spiga O, et al
    A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization.
    Biochem Biophys Res Commun. 2020;528:35-38.
    PubMed     Abstract available
    
    
    
97. WAKIDA H, Kawata K, Yamaji Y, Hattori E, et al
    Stability of RNA sequences derived from the coronavirus genome in human cells.
    Biochem Biophys Res Commun. 2020;527:993-999.
    PubMed     Abstract available
    
    
    June 2020
98. ZENG W, Liu G, Ma H, Zhao D, et al
    Biochemical characterization of SARS-CoV-2 nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;527:618-623.
    PubMed     Abstract available
    
    
    
99. OTHMAN H, Bouslama Z, Brandenburg JT, da Rocha J, et al
    Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
    Biochem Biophys Res Commun. 2020;527:702-708.
    PubMed     Abstract available
    
    
    
100. LI Y, Li H, Zhou L
     EZH2-mediated H3K27me3 inhibits ACE2 expression.
     Biochem Biophys Res Commun. 2020;526:947-952.
     PubMed     Abstract available
     
     
     May 2020
101. LUAN J, Lu Y, Jin X, Zhang L, et al
     Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
     Biochem Biophys Res Commun. 2020;526:165-169.
     PubMed     Abstract available
     
     
     
102. QI F, Qian S, Zhang S, Zhang Z, et al
     Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
     Biochem Biophys Res Commun. 2020;526:135-140.
     PubMed     Abstract available
     
     
     April 2020
103. HUANG Q, Zhong Y, Li J, Ye Y, et al
     Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
     Biochem Biophys Res Commun. 2020 Apr 13. pii: S0006-291X(20)30756.
     PubMed     Abstract available
     
     
     February 2020
104. MORRIS AK, Wang Z, Ivey AL, Xie Y, et al
     Cellular mRNA export factor UAP56 recognizes nucleic acid binding site of influenza virus NP protein.
     Biochem Biophys Res Commun. 2020 Feb 19. pii: S0006-291X(20)30327.
     PubMed     Abstract available
     
     
     December 2019
105. CHEN F, Yang L, Huang Y, Chen Y, et al
     Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus.
     Biochem Biophys Res Commun. 2019 Dec 13. pii: S0006-291X(19)32363.
     PubMed     Abstract available
     
     
     October 2019
106. NISHIOKA K, Daidoji T, Nakaya T
     Demethylation around the transcriptional start site of the IFN-beta gene induces IFN-beta production and protection against influenza virus infection.
     Biochem Biophys Res Commun. 2019 Oct 5. pii: S0006-291X(19)31874.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: